CollPlant Biotechnologies Quarterly Balance Sheet
NASDAQ: OPHIHealth CareIndustrial SpecialtiesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
CollPlant Biotechnologies financial position
As of Dec 31, 2025, CollPlant Biotechnologies reported total assets of $10.8 million, down 78.9% from a year earlier against total liabilities of $4.7 million. Shareholders' equity stood at $6.1 million, or 56.4% of assets. The company held $5.6 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 2.53, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
CollPlant Biotechnologies balance sheet (quarterly)
| Quarter (USD) | Q4 20252025-12-31 | Q4 20242024-12-31 | Q4 20232023-12-31 | Q4 20222022-12-31 | Q4 20212021-12-31 | Q4 20202020-12-31 | Q4 20192019-12-31 | Q4 20182018-12-31 | Q4 20172017-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 5.59M | 11.91M | 26.67M | 29.65M | 13.15M | 3.33M | 3.79M | 5.35M | 5.28M |
| Receivables | 1.00K | 150.00K | — | 9.00K | 270.00K | 830.00K | 79.00K | — | — |
| Inventory | 573.00K | 440.00K | 714.00K | 1.43M | 1.08M | 1.26M | 888.00K | 814.00K | 202.00K |
| Total Current Assets | 6.75M | 13.18M | 28.02M | 31.66M | 45.09M | 5.68M | 5.04M | 7.17M | 6.46M |
| Property, Plant & Equipment | 1.46M | 2.29M | 2.79M | 2.97M | 2.73M | 2.11M | 2.33M | 1.41M | 1.03M |
| Intangible Assets | 73.00K | 131.00K | 188.00K | 245.00K | 243.00K | 82.00K | — | — | — |
| Total Assets | 10.79M | 18.71M | 34.13M | 37.77M | 51.22M | 10.84M | 10.75M | 8.75M | 8.09M |
| Accounts Payable | 610.00K | 870.00K | 980.00K | 1.13M | 1.03M | 798.00K | 833.00K | — | — |
| Short-Term Debt | — | — | — | 321.00K | 219.00K | — | — | — | — |
| Total Current Liabilities | 2.67M | 2.97M | 3.25M | 3.10M | 3.01M | 3.39M | 3.46M | 2.23M | 1.42M |
| Long-Term Debt | — | — | — | — | 30.00K | 11.00K | 63.00K | — | 2.00M |
| Total Liabilities | 4.70M | 5.25M | 5.79M | 5.49M | 6.10M | 6.36M | 6.66M | 3.33M | 5.47M |
| Shareholders' Equity | 6.08M | 13.46M | 28.34M | 32.28M | 45.12M | 4.48M | 4.09M | 5.42M | 5.17M |
| Retained Earnings | -124.84M | -113.35M | -96.74M | -89.72M | -72.80M | -73.03M | -67.26M | -56.10M | -50.30M |
| Total Debt | — | — | — | 321.00K | 249.00K | 11.00K | 63.00K | — | 2.00M |
| Net Cash (Debt) | 5.59M | 11.91M | 26.67M | 29.33M | 12.90M | 3.32M | 3.73M | 5.35M | 3.28M |
| Shares Outstanding | 12.80M | 11.45M | 11.45M | 11.19M | 10.77M | 6.96M | 5.67M | — | — |
This table shows 9 quarterly periods of CollPlant Biotechnologies's balance sheet, from Q4 2025 back to Q4 2017, across 17 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow OPHI's reporting calendar. What is a balance sheet?